SPYRE THERAPEUTICS, INC. (SYRE)
Spyre Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $463.5 Million
Spyre Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $463.5 Million
MGP Ingredients to Report First Quarter 2026 Financial Results on Wednesday, April 29, 2026
W. R. Berkley Corporation Names Christopher T. Reichardt President of Berkley Oil & Gas
Trupanion Announces First Quarter 2026 Earnings Release and Conference Call
Fair Isaac Corporation Announces Date for Reporting of Second Quarter Fiscal 2026 Financial Results
Ardent Health Announces First Quarter 2026 Results Conference Call and Webcast Date
onsemi to Announce First Quarter Financial Results
Kingstone Schedules First Quarter 2026 Earnings Release and Conference Call
South Plains Financial, Inc. Declares Quarterly Cash Dividend
NPK International Announces First Quarter 2026 Results Conference Call and Webcast Date